Do you have a question or suggestion?

Fill out the form and we will contact you as soon as possible. Thank you for your interest!



    Main Contacts  Pro EuroDILINet

    General enquiries:

    Dr Raul ANDRADE

    Prof Guruprasad AITHAL
    Vice Chair

    Dr Rossella MAGLI
    Science officer

    Ms Nathalie WARENGHIEN
    Administrative officer

    Dr. Michael Merz

    Dr. Michael Merz


    Deputy for Leader WG2 (

    University Hospital Zurich (Switzerland)


    • Clinical Pharmacologist and Drug Safety Expert
    • 1993-1998: Quintiles Research, Freiburg, Germany
    • 1998-2017: Novartis Pharma AG, Basel, Switzerland
      • Head Modeling and Simulation, Clinical Pharmacology
      • Global Safety Profiling Director, Exploratory Clinical Development
      • Section Head Systems Toxicology & Head Safety Networks, Translational Sciences
      • Chair investigative Liver Expert Team, Novartis Institutes for BioMedical Research
    • 2010-2016: Project coordinator IMI SAFE-T consortium for clinical safety biomarker qualification
    • Since 05/2017: Independent consultant, focus on Drug-Induced Liver Injury; Consortium Coordinator at University Hospital Zürich, Switzerland
    • In charge of proposal H2020-JTI-IMI2-2017-13-two-stage: Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease